AP-1 |
Activator protein-1 |
CSC |
Cancer stem cell |
DAPI |
4′,6-Diamidino-2-phenyindole, dilactate |
DMEM |
Dulbecco’s modification of Eagle medium |
EC |
Endothelial cell |
ECL |
Enhanced chemiluminescence |
EMT |
Epithelial-Mesenchymal Transition |
ERK |
Extracellular signal-regulated kinase |
FBS |
Fetal bovine serum |
FGF-2 |
Fibroblast growth factor-2 |
HIF1α |
Hypoxia-inducible factor 1alpha |
IC50 |
Inhibitory concentration that decreases cell viability by 50% |
JAK |
Janus kinase |
MAPK |
Mitogen-activated protein kinase |
MMP |
Matrix metalloproteinase |
mTOR |
Mammalian target of rapamycin |
MTT |
3-(4,5-Dimethylthiazol-2-yl)-2,5-biphenyl tetrazolium bromide |
NF-κB |
Nuclear factor kappa B |
NKP |
Sodium/potassium (Na+/K+)-ATPase pump |
OCT |
octamer-binding transcription factor |
ROS |
Reactive oxygen species |
RPMI |
Roswell Park Memorial Institute medium |
RT-R |
Radioresistant |
SDS-PAGE |
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis |
SHP-1 |
Src homology region 2 domain-containing phosphatase 1 |
STAT |
Signal transducer and activator of transcription |
TNBC |
Triple negative breast cancer |